Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-12-02

Clinical Trial Update: Event Rate and Effects of Stimulants in ADHD [Phase 3]

View source ↗

Summary

A Phase 3 ADHD trial was withdrawn, providing no conclusive results for stimulant effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Ghent | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: WITHDRAWN